Gadoxetate disodium

DRUG5 trials

Sponsors

M.D. Anderson Cancer Center, Duke University, University of Southern California, Guerbet, University of Colorado, Denver

Conditions

Adult Hepatocellular CarcinomaAdvanced Adult Hepatocellular CarcinomaBCLC Stage 0 Adult Hepatocellular CarcinomaBCLC Stage A Adult Hepatocellular CarcinomaBCLC Stage B Adult Hepatocellular CarcinomaBCLC Stage C Adult Hepatocellular CarcinomaBCLC Stage D Adult Hepatocellular CarcinomaCognitive Function

Phase 1

MRI With Gadoxetate Disodium in Measuring Tumors in Patients With Liver Cancer

CompletedNCT02578602

University of Southern CaliforniaAdult Hepatocellular Carcinoma, Advanced Adult Hepatocellular Carcinoma, BCLC Stage 0 Adult Hepatocellular Carcinoma +6

Start: 2010-10-31End: 2015-06-30Updated: 2015-10-19

Phase 4

Eovist vs. Dotarem Healthy Volunteer MRI

CompletedNCT02431598

Duke UniversityTransient Severe Arterial Phase Motion

Start: 2015-06-30End: 2015-09-30Updated: 2017-04-14

Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years

RecruitingNCT04373564

GuerbetCognitive Function, Contrast Media, Motor Function

Start: 2021-03-24End: 2028-12-31Target: 2076Updated: 2026-01-22

Comparison of Contrast Agents in Liver MR for the Detection of Hepatic Metastases

TerminatedNCT04973007

University of Colorado, DenverColorectal Cancer, Liver Metastases, Oligometastatic Disease

Start: 2021-06-22End: 2025-05-08Updated: 2025-07-02

Unknown Phase

Contrast-enhanced MRI in Detecting Benign and Malignant Liver Lesions

Active, not recruitingNCT02156739

M.D. Anderson Cancer CenterHepatocellular Carcinoma, Liver and Intrahepatic Bile Duct Disorder, Metastatic Malignant Neoplasm in the Liver +1

Start: 2014-10-13End: 2026-06-01Updated: 2025-12-22